- Women with type 2 diabetes may need more insulin per pound than men
- This could change how doctors personalize treatment
- Findings are early clues — not ready for clinics yet
Doctors may need to adjust insulin based on sex — not just weight or diet.
Maria takes insulin every day for type 2 diabetes. So does James. They weigh the same. They eat similar meals. But Maria’s blood sugar stays harder to control — and she needs more insulin. Why?
It’s not just her diet or routine. New research says sex may play a hidden role.
Scientists reviewed 24 studies involving thousands of adults with diabetes. They wanted to know: Do women and men respond the same way to insulin?
The answer? Not always.
Millions of people rely on insulin to manage diabetes. In the U.S. alone, over 37 million have the condition. About 1 in 4 use insulin.
For years, treatment has focused on blood sugar levels, weight, and diet. But one key factor has been overlooked: biological sex.
Women and men differ in body fat, hormones, and even how cells use insulin. Yet most guidelines don’t account for this.
Many patients like Maria feel frustrated. They follow their plan — but still struggle. Could the problem be built into their biology?
The surprising shift
For a long time, experts assumed insulin worked the same in everyone. Dose adjustments were based on weight, age, and glucose readings.
But here’s the twist: women with type 2 diabetes often need higher doses of insulin per pound of body weight than men.
The review found moderate evidence that women required more insulin to achieve similar control. The gap remained even after adjusting for weight.
In contrast, men were slightly more likely to hit target blood sugar levels.
This doesn’t mean women are “worse” at managing diabetes. It means their bodies may process insulin differently.
What scientists didn’t expect
In type 1 diabetes, the story flips.
Women did not show a clear difference in reaching the common goal of HbA1c under 7%. But they trended toward better time-in-range — meaning their blood sugar stayed stable more often during the day.
That’s surprising. It suggests women with type 1 might actually respond better to insulin in daily life — even if lab numbers look the same.
But in type 2, the opposite pattern emerged. Women needed more insulin. And they didn’t reach targets as often.
Why the difference? It may come down to how type 1 and type 2 affect the body — and how sex hormones interact with insulin.
Think of insulin like a key. It unlocks cells so sugar from food can enter and be used for energy.
In type 1 diabetes, the body makes little or no insulin. So patients need to inject the key.
In type 2, the body makes insulin — but the locks are rusty. Cells resist the key. Over time, the body can’t keep up.
Now, add sex into the mix.
Women tend to have more body fat, especially around the hips and thighs. Fat tissue can make cells less sensitive to insulin — like a stiff lock.
Estrogen and other hormones also affect how the body stores and uses sugar.
So even at the same weight, a woman’s body may need more insulin to force the keys into the locks.
The real-world gap
Another puzzle: low blood sugar (hypoglycemia).
Women in hospitals seemed to have a lower risk. But outside the hospital, they faced a higher risk — though the data was mixed.
Experts think this may be due to monitoring differences. In hospitals, doses are tightly controlled. At home, daily life — meals, stress, activity — adds complexity.
Women may also be more likely to report symptoms. Or their bodies may react differently under stress.
Either way, the setting changes the outcome.
This doesn’t mean this treatment is available yet.
The review analyzed data from over 24 studies. Most included adults with type 1 or type 2 diabetes on insulin therapy. Researchers looked at HbA1c, time-in-range, insulin doses, and hypoglycemia — all broken down by sex.
For type 2 diabetes, the result was clear: women needed higher weight-adjusted insulin doses. The effect size was small to moderate — but consistent across studies.
Men were more likely to reach HbA1c targets, though the difference was not statistically strong.
In type 1 diabetes, no major gap appeared in HbA1c control. But women spent more time in the target glucose range — a sign of smoother, more stable control.
The hidden pattern
These findings don’t prove cause and effect. But they reveal a pattern: sex matters in insulin response — but how it matters depends on the type of diabetes.
It’s not a one-size-fits-all difference. It’s a clue that personalized care should go deeper than numbers on a chart.
But there’s a catch.
Researchers call the results “hypothesis-generating.” That means they’re not ready to change guidelines — but they should spark new questions.
“We’ve long known that sex influences heart disease, pain, and drug metabolism,” said one expert not involved in the study. “It’s time we apply that lens to diabetes.”
The review highlights a bigger issue: most medical research doesn’t analyze results by sex. Even when data exists, it’s often pooled together.
That can hide important differences — and leave patients with suboptimal care.
Right now, this won’t change your insulin prescription.
Doctors aren’t being told to give women higher doses. The evidence isn’t strong enough.
But if you’re struggling to control your blood sugar — especially if you’re a woman with type 2 diabetes — this research may explain part of why.
Talk to your doctor. Share your full experience. Ask whether your treatment plan considers more than just weight and diet.
Personalized care should include you — your body, your life, your biology.
The limits of the data
Many studies were small. Some had weak designs. Others didn’t control for key factors like body composition, activity level, or hormone changes.
The certainty of evidence was rated “very low” to “low” for most outcomes.
Also, most data came from high-income countries. Results may not apply equally worldwide.
And the review couldn’t separate the effects of social factors — like access to care, stress, or food security — from biological ones.
What happens next
Future trials need to track and report results by sex from the start. Researchers must control for body fat, hormones, and lifestyle.
Larger, more diverse studies could confirm whether sex-specific dosing improves outcomes.
For now, this is a wake-up call — not a new rule.
But it may lead to smarter, fairer diabetes care for everyone.
